Neonatal haemostatic parameters in correlation to gestational age and birth weight

The aim of our study was to establish reference ranges for neonatal coagulation and fibrinolysis parameters and to investigate their relationship with gestational age (GA) and birth weight (BW).

• Publication year

  2022

• Venue

  International Journal of Laboratory Hematology

• Publication date

  2022-07-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/ijlh.13932PMID 35815444
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neonatal Sepsis and Hemostasis

  2022cited by this paper
• Vitamin K Deficiency Bleeding in Infancy

  2020cited by this paper
• International Council for Standardization in Haematology Recommendations for Hemostasis Critical Values, Tests, and Reporting

  2019cited by this paper
• Tissue-type plasminogen activator contributes to remodeling of the rat ductus arteriosus

  2018cited by this paper
• Incidence and Consequences of Neonatal Alloimmune Thrombocytopenia: A Systematic Review

  2014cited by this paper
• Developmental hemostasis: recommendations for laboratories reporting pediatric samples

  2012cited by this paper
• The conundrum of neonatal coagulopathy.

  2012cited by this paper
• Developmental haemostasis: secondary haemostasis.

  2011cited by this paper
• Haemostatic profile of healthy premature small for gestational age neonates.

  2010cited by this paper
• Haemostatic profile of full-term, healthy, small for gestational age neonates.

  2009cited by this paper
• The Evolution of

  2006cited by this paper
• Developmental haemostasis

  2006cited by this paper
• Regulation and interactions in the activation of cell-associated plasminogen

  2004cited by this paper
• Effects of gestational age and prenatal and perinatal events on the coagulation status in premature infants

  2003influential reference
• Bleeding in the newborn.

  2001cited by this paper
• Progressive and transient expression of tissue plasminogen activator during fetal development.

  2000cited by this paper
• Correlation between the Functional Assay for Activated Protein C Resistance and Factor V Leiden in the Neonate

  1997cited by this paper
• Evolution of blood coagulation activators and inhibitors in the healthy human fetus.

  1996cited by this paper
• Extracellular Matrix‐Degrading Proteinases in the Nervous System

  1994cited by this paper
• Maturation of the hemostatic system during childhood.

  1992cited by this paper
• The expression of tissue and urokinase-type plasminogen activators in neural development suggests different modes of proteolytic involvement in neuronal growth.

  1992cited by this paper
• Thrombin Generation in Newborn Plasma Is Critically Dependent on the Concentration of Prothrombin

  1990cited by this paper
• Blood coagulation factors in human embryonic-fetal development: preferential expression of the FVII/tissue factor pathway

  1990cited by this paper
• Blood coagulation factors in human embryonic-fetal development: preferential expression of the FVII/tissue factor pathway.

  1990cited by this paper
• Development of the Hemostatic System in the Neonate and Young Infant

  1990cited by this paper
• Protein S and C4b‐binding protein in fetal and neonatal blood

  1988cited by this paper
• Levels and plasma distribution of free and C4b-BP-bound protein S in human fetuses and full-term newborns.

  1988cited by this paper
• Evidence for tissue factor-dependent activation of the classic extrinsic coagulation mechanism in blood obtained from bleeding time wounds.

  1988cited by this paper
• Development of the human coagulation system in the healthy premature infant.

  1988cited by this paper
• Clinical impact of neonatal thrombocytopenia.

  1987cited by this paper
• Inhibition of the activation of Hageman factor (factor XII) by complement subcomponent C1q.

  1987cited by this paper
• Development of the human coagulation system in the full-term infant.

  1987cited by this paper
• Newborn haemostasis.

  1985cited by this paper
• Protein C Level at Birth

  1984cited by this paper
• Plasma Protease Inhibitors in Premature Infants: Influence of Gestational Age, Postnatal Age, and Health Status 1

  1983influential reference
• Normal and abnormal bleeding times in neonates and young children utilizing a fully standardized template technic.

  1980cited by this paper
• [Use of cephalin in coagulation tests].

  1957cited by this paper
• Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure.

  1953cited by this paper

• Comparative Analysis of Therapeutic Efficacy and Adverse Reactions among Various Thrombolytic Agents

  2024cites this paper
• Comparison of standard and global hemostasis assays in cord and peripheral blood of newborns

  2024cites this paper
• Clinical, Laboratory, Molecular, and Reproductive Aspects of Combined Deficiency of Factors V and VIII

  2024cites this paper
• Neonatal hemostasis and the use of thromboelastography/rotational thromboelastometry in the neonatal period.

  2023cites this paper